Congress Validates the Decree that Reforms the Pharmaceutical Copay with New Price Caps with the Abstention of PP, ERC and Junts
10 Articles
10 Articles
The Congress has validated the royal decree establishing a new pharmaceutical co-payment, which in general means a reduction in the cost of medicines for the majority of citizens. The new system adapts the pharmaceutical contribution to the real economic capacity of the citizenry and improves the protection for polymedicated patients. How? Incorporating new stages of contribution and monthly progressive caps according to the income, without incr…
The Congress of Deputies has validated the reform of the pharmaceutical co-payment system to make it more proportional to income.
On Thursday, the Congress of Deputies approved the decree that reforms the pharmaceutical co-payments and sets new price ceilings for medicines according to the patients' income. The plenary session gave the green light to the measure promoted by the Government, which already approved the norm two weeks ago but could still decline without the approval of the groups. Finally, with 164 yeses, 33 noes de Vox and 140 abstentions of the PP, ERC and J…
Excerpt from the royal decree on pharmaceutical co-payments. In the vote on the 28th, the royal decree received 164 votes in favor, 33 against, and 149 abstentions. As mentioned in the published information, Vox was the only party that voted against it, while the PP abstained.
The Spanish Congress of Deputies ratified on Thursday, with 164 votes in favor, the reform of the pharmaceutical co-payment system promoted by the Ministry of Health, which came into effect on May 14th after its publication in the Official State Gazette (BOE). The Minister of Health, Mónica García, argued during the debate that the new model aims to "make the system more progressive and fairer," placing particular emphasis on protecting patients…
With abstentions from the People's Party (PP), Junts, and ERC, and Vox voting against, the Spanish Congress of Deputies on Thursday ratified the decree reforming pharmaceutical co-payments, which lowers the prices of medications included in the National Health System (SNS) based on patients' income. Thus, the two main opposition parties did not vote in favor of this significant healthcare measure. Thursday's plenary session approved the measure,…
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
